Pichu S, Patel BM, Apparsundaram S, Goyal RK. Role of biomarkers in predicting diabetes complications with special reference to diabetic foot ulcers. Vol. 11, Biomarkers in Medicine. 2017. p. 377–88.

Atlaw, Asegdew, et al. "Bacterial isolates from diabetic foot ulcers and their antimicrobial resistance profile from selected hospitals in Addis Ababa, Ethiopia." Frontiers in Endocrinology 13 (2022): 987487.‏

Lipsky BA, Berendt AR, Cornia PB, Pile JC, Peters EJ, Armstrong DG, et al. Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections. Clin Infect Dis 2012; 54: e132–e173.

. Singh S, Pai DR, Yuhhui C. Diabetic foot ulcer − diagnosis and management. Clin Res Foot Ankle 2013; 1:120.

Saleem, Sheikh Mohd, S. S. Khan, and Shah Sumaya Jan. "Role of serum procalcitonin level in early diagnosis of bacterial pneumonia in children, a hospital-based study." Int J Res Med Sci 4 (2016): 1518-1521.‏

Oberhoffer M, Stonans I, Russwurm S, Stonane E, Vogelsang H, Junker U, et al. Procalcitonin expression in human peripheral blood mononuclear cells and its modulation by lipopolysaccharides and sepsis-related cytokines in vitro. J Lab Clin Med 1999; 134:49–55.

Bongiovanni C, Magrini L, Salerno G, Gori CS, Cardelli P, Hur M, et al. Serum Cystatin C for the Diagnosis of Acute Kidney Injury in Patients Admitted in the Emergency Department. Vol. 2015, Disease Markers. 2015.

Uzun G, Solmazgul E, Curuksulu H, Turhan V, Ardic N, Top C, et al. Procalcitonin as a diagnostic aid in diabetic foot infections. Tohoku J Exp Med 2007; 213:305–312.

Jeandrot A, Richard JL, Combescure C, Jourdan N, Finge S, Rodier M, et al. Serum procalcitonin and C-reactive protein concentrations to distinguish mildly infected from non-infected diabetic foot ulcers: a pilot study. Diabetologia 2008; 51:347–352.

Al-Nori MKJ, Ahmed AJ. The role of serum cystatin C as an early predictor for the diagnosis of chronic kidney disease in Mosul City. Vol. 14, Iraqi Journal of Pharmacy. 2019. p. 76–8.

PEI, Yuanyuan, et al. Serum cystatin C, kidney injury molecule-1, neutrophil gelatinase-associated lipocalin, klotho and fibroblast growth factor-23 in the early prediction of acute kidney injury associated with sepsis in a Chinese emergency cohort study. European journal of medical research, 2022, 27.1: 39.‏

Brozat, Jonathan Frederik, et al. "Elevated Serum KIM-1 in Sepsis Correlates with Kidney Dysfunction and the Severity of Multi-Organ Critical Illness." International Journal of Molecular Sciences 25.11 (2024): 5819.‏

Seibert, Felix S., et al. “Prognostic value of urinary calprotectin, NGAL and KIM-1 in chronic kidney disease.” Kidney and Blood Pressure Research 43.4 (2018): 1255–1262.

JAFARI, Nematollah Jonaidi, et al. Can procalcitonin be an accurate diagnostic marker for the classification of diabetic foot ulcers?. International journal of endocrinology and metabolism, 2014, 12.1.

El-Kafrawy NA, Shaaban MA, Korany MA, Sonbol AA, Ata MB. Procalcitonin as a marker of diabetic foot ulcer infection. Vol. 31, The Egyptian Journal of Internal Medicine. 2019. p. 652–7.

MASSARA, Mafalda, et al. The role of procalcitonin as a marker of diabetic foot ulcer infection. International wound journal, 2017, 14.1: 31–34.

Umapathy, Dhamodharan, et al. “Potential of circulatory procalcitonin as a biomarker reflecting inflammation among South Indian diabetic foot ulcers.” Journal of vascular surgery 67.4 (2018): 1283–1291.

ONG, Eric, et al. The role of inflammatory markers: WBC, CRP, ESR, and neutrophil-to-lymphocyte ratio (NLR) in the diagnosis and Management of Diabetic Foot Infections. In: Open Forum Infectious Diseases. Infectious Diseases Society of America, 2015. p. 1526.

Ai L, Hu Y, Zhang X, Zeng H, Zhao J, Zhao J, et al. High cystatin C levels predict undesirable outcome for diabetic foot ulcerations. Vol. 24, Wound Repair and Regeneration. 2016. p. 560–7.

An, Jingsi, et al. “Value of cystatin C in predicting recurrence in patients with severe diabetic foot and diabetic foot ulcer.” Biomarkers in Medicine 17.5 (2023): 287–296.

Fatemi, Shahab, et al. “Copeptin, B-type natriuretic peptide and cystatin C are associated with incident symptomatic PAD.” Biomarkers 24.6 (2019):615–621.

Yin, Caixia, and Ningning Wang. “Kidney injury molecule-1 in kidney disease.” Renal failure 38.10 (2016): 1567–1573.

De Silva, P. Mangala CS, et al. “Urinary biomarkers of renal injury KIM-1 and NGAL: reference intervals for healthy pediatric population in Sri Lanka.” Children 8.8 (2021): 684.